The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Nuclear Medicine Radioisotopes Market In 2026 And 2030?
The nuclear medicine radioisotopes market has seen significant expansion in recent years. Its valuation is predicted to increase from $8.85 billion in 2025 to $9.58 billion in 2026, advancing at a compound annual growth rate (CAGR) of 8.2%. The historical growth of this market can be linked to the widespread application of technetium-99m in diagnostic imaging, the rising embrace of nuclear cardiology procedures, the growing occurrence of cancer and thyroid conditions, the enlargement of hospital-based nuclear medicine departments, and the initial successful outcomes of radioisotope-based therapies.
The nuclear medicine radioisotopes market is poised for significant expansion in the upcoming years. Its valuation is projected to reach $12.75 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. This anticipated growth is driven by factors such as an increasing demand for personalized cancer treatment, the expanding use of lutetium-177 and actinium-225 therapies, the development of PET imaging infrastructure, rising investments in cyclotron and reactor facilities, and the greater adoption of nuclear medicine in emerging economies. Noteworthy trends for the forecast period include the increasing integration of theranostics in oncology care, a heightened demand for PET and SPECT imaging procedures, the expanded application of targeted alpha and beta emitters, the diversification of nuclear medicine into cardiology and neurology, and a stronger emphasis on domestic radioisotope production.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16132&type=smp
Which Growth Factors Are Strengthening The Nuclear Medicine Radioisotopes Market Landscape?
The escalating incidence of cardiovascular diseases is anticipated to fuel the expansion of the nuclear medicine radioisotope market moving forward. Cardiovascular diseases are a collection of conditions that affect the heart and blood vessels. The rise in cardiovascular disease cases stems from sedentary lifestyles, poor dietary habits, increasing rates of obesity, and aging populations. Nuclear medicine radioisotopes are invaluable for diagnosing, evaluating, and managing cardiovascular diseases by offering detailed insights into cardiac function, perfusion, and tissue viability, which are essential for accurate diagnosis and effective treatment planning. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing number of cardiovascular disease cases is propelling the growth of the nuclear medicine radioisotope market.
What Are The Core Segment Classifications In The Nuclear Medicine Radioisotopes Market?
The nuclear medicine radioisotopes market covered in this report is segmented –
1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types
2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users
Subsegments:
1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)
2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging
3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)
4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging
5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging
6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment
7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment
8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo), Alpharadin For Bone Metastasis Treatment
9) By Alpharadin (Radium-223 Alpha Emitters): Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)
10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)
Which Trends Are Influencing The Expansion Of The Nuclear Medicine Radioisotopes Market?
Leading companies in the nuclear medicine radioisotopes market are dedicated to developing inventive solutions, such as next-generation theranostic radiopharmaceuticals, to improve the precision of imaging and the effectiveness of targeted treatments. These advanced theranostic radiopharmaceuticals are sophisticated radioactive agents crafted to both identify and accurately treat diseases by specifically targeting particular cells within the body with great precision. For example, in November 2025, the University of California, a US-based research university, initiated a fully independent Department of Nuclear Medicine & Theranostics, moving nuclear medicine from its previous position under a broader radiology department. This new department intends to accelerate the integration of advanced imaging and targeted radiopharmaceutical therapies. It also aims to bolster research, education, and clinical programs to further precision medicine and stimulate innovations in theranostic treatments.
Who Are The Businesses Driving Activity In The Nuclear Medicine Radioisotopes Market?
Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacibasi-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation
Access The Complete Nuclear Medicine Radioisotopes Market Report:
Which Region Stands As The Largest Contributor To The Nuclear Medicine Radioisotopes Market?
North America was the largest region in the nuclear medicine radioisotopes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Nuclear Medicine Radioisotopes Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=16132&type=smp
Browse Through More Reports Similar to the Global Nuclear Medicine Radioisotopes Market 2026, By The Business Research Company
Nuclear Medicine Radioisotopes Market Report 2026
Diagnostic Radioisotopes Market Report 2026
https://www.thebusinessresearchcompany.com/report/diagnostic-radioisotopes-global-market-report
Nuclear Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model